// App-Quantinova.ai

: Assessing the Burden of Adverse Events in a Head-to-Head Trial of Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia (CLL)

Researchers

Presenter

  • John F. Seymour

Principal Investigators

  • John C. Byrd

  • Talha Munir

  • Paolo Ghia

  • Arnon P. Kater

  • Asher Chanan-Khan

  • Richard R. Furman

  • Susan O'Brien

  • Jennifer R. Brown

  • Anthony R. Mato

  • Stephan Stilgenbauer

  • Thomas Fehn

  • Paulo Andre P. de Miranda

  • Kara Higgins

  • Ellie John

  • Marianne de Borja

  • Wojciech Jurczak

  • Jennifer A. Woyach

Medical Centers

  • MSC National Research Institute of Oncology, Krakow, Poland

  • St. James's University Hospital, Leeds, United Kingdom

  • Chao Family Comprehensive Cancer Center, University of California-Irvine, Irvine, CA

  • Peter MacCallum Cancer Centre & Royal Melbourne Hospital, Victoria, Australia

  • MAYO CLINIC JACKSONVILLE, Jacksonville, FL

  • Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy

  • Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY

  • University of Ulm, Ulm, Germany

  • Memorial Sloan Kettering Cancer Center, New York, NY

  • Amsterdam University Medical Centers, University of Amsterdam, on behalf of Hovon, Amsterdam, Netherlands

  • Department of Internal Medicine, University of Cincinnati, Cincinnati, OH

  • Dana-Farber Cancer Institute, Boston, MA

  • Weill Cornell Medicine, New York Presbyterian Hospital, New York, NY

Locations

  • United States

  • Poland

  • Germany

  • United Kingdom

  • Italy

  • Netherlands

  • Canada

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Chronic Lymphocytic Leukemia

Biomarkers

  • Bruton tyrosine kinase

Drug/Treatment

  • ACP-196

  • Ibrutinib

Outcome

  • N/A

Study Design

  • Active Comparator

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved